Potential clinical indications for a CCK2 receptor antagonist
Author:
Publisher
Elsevier BV
Subject
Drug Discovery,Pharmacology
Reference48 articles.
1. Gastrin receptor pharmacology;Dockray;Curr Gastroenterol Rep,2012
2. Novel roles of gastrin;Dimaline;J Physiol (Lond),2014
3. Cholecystokinin antagonists: pharmacological and therapeutic potential;Herranz;Med Res Rev,2003
4. Reflections on some pilot trials of gastrin receptor blockade in pancreatic cancer;Black;Eur J Cancer,2009
5. The cholecystokinin CCK2 receptor antagonist, JNJ-26070109, inhibits gastric acid secretion and prevents omeprazole-induced acid rebound in the rat;Barrett;Br J Pharmacol,2012
Cited by 18 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Netazepide, an Antagonist of Cholecystokinin Type 2 Receptor, Prevents Vincristine-Induced Sensory Neuropathy in Mice;Pharmaceuticals;2024-01-23
2. Precision peptide theranostics: developing N- to C-terminus optimized theranostics targeting cholecystokinin-2 receptor;Theranostics;2024
3. Neuroendocrine mechanism of gastric acid secretion: Historical perspectives and recent developments in physiology and pharmacology;Journal of Neuroendocrinology;2023-06-15
4. Bromophenols from Symphyocladia latiuscula (Harvey) Yamada as Novel Cholecystokinin 2 Receptor Antagonists;Journal of Integrative Neuroscience;2023-01-05
5. New Developments in Gastric Neuroendocrine Neoplasms;Current Oncology Reports;2022-01
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3